Lantern Pharma Inc.LTRNNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank50
3Y CAGR-29.8%
5Y CAGR+78.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-29.8%/yr
Annual compound
5Y CAGR
+78.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
17.9x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$25.57M-41.4%
2023$43.65M-25.8%
2022$58.84M-20.4%
2021$73.95M+263.2%
2020$20.36M+1321.2%
2019$1.43M+218.5%
2018$449831.00-